Event name: BioPh China 2017
Event Location: Shanghai New International Expo Centre
Event Date: 20-22 June, 2017
Organizer: UBM EMEA, CCCMHPIE, UBM Sinoexpo
Phone: +86-21-3339 2421
Email Address: email@example.com
BioPh China 2017, hosted by UBM EMEA and China Chamber of Commerce of Medicines & Health Products Importers & Exporters and co-organized by UBM Sinoexpo, will be held on 20 - 22 June, 2017 at Hall E2 in Shanghai New International Expo Centre.
The emerging industry of bio-medicine has become one of the strategic directions and focal development points of the pharmaceutical industry in coming years. This focus is supported by number of factors: recent completion of the Development of Pharmaceutical Industry for the Thirteenth Five-Year Plan Period in 2015, as well as by Made in China 2025 listing biomedicine represented by gene drugs, monoclonal antibody/protein drugs and vaccines as one of the ten key sectors to be develop in the future.
First launched in 2012, BioPh China has become one of Asia's top focused exhibitions in the fields of gene engineering, antibody engineering, cell culture, biological Instrument, etc. It establishes itself as an industry-leading international platform in Asia for the people from pharmaceutical or biotech companies, research institutes and all other industry stakeholders to meet, network and discuss latest industry trends, partnership models and investment opportunities in Asia and Global.
Up to now, domestic pharmaceutical giants such as Gan & Lee Pharmaceuticals, 3SBIO, Dongbao Enterprise Group, Shenzhen Mellow Hope, and Sinobioway Group have all confirmed their participation at BioPh China 2017, showcasing the most advanced R&D achievements, technologies and solutions of biomedical technical fields, including protein, antigen, polypeptide, enzyme, bioprocessing, antibody, biological agent, bio-manufacturing, cell biology, clinical trial, new drug R&D, genomics, genetics, personalized medicine, stem cell research, therapeutics, vaccine, biofuel, nanotechnology, biological information, biological information technology, and platform technology.
To enhance the communication and cooperation between Chinese biomedical enterprises and international enterprises, the 4th BioPh Summit China, as the most important concurrently held onsite event, will gather industry-university-research elites and leaders in biomedical industry to discuss the course for future development of the industry. The summit will focus on the recent dynamics of Chinese and foreign policies, and global market opportunities and other strategic topics, as well as Chinese and foreign latest research achievements in recombinant protein drugs, antibodies and vaccines, to provide industry practitioners with an excellent platform for sharing industry information, R&D experience and case analysis. BioPh China 2017 will merge the new thinking and concepts into the Chinese biomedical industry through linkage of "exhibition" and "conference".